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Summary
The human deafness-pigmentation syndromes, Waardenburg syndrome (WS) type 2a, and Tietz syndrome are
characterized by profound deafness but only partial cutaneous pigmentary abnormalities. Both syndromes are
caused by mutations in MITF. To illuminate differences between cutaneous and otic melanocytes in these
syndromes, their development and survival in heterozygous Microphthalmia-White (Mitf Mi-wh/+) mice were
studied and hearing function of these mice characterized. Mitf Mi-wh/+ mice have a profound hearing deficit,
characterized by elevated auditory brainstem response thresholds, reduced distortion product otoacoustic
emissions, absent endocochlear potential, loss of outer hair cells, and stria vascularis abnormalities.Mitf Mi-wh/+
embryos have fewer melanoblasts during embryonic development than their wild-type littermates. Although
cochlear melanocytes are present at birth, they disappear from the Mitf Mi-wh/+ cochlea between P1 and P7.
These findings may provide insight into the mechanism of melanocyte and hearing loss in human deafness-
pigmentation syndromes such as WS and Tietz syndrome and illustrate differences between otic and follicular
melanocytes.
Introduction
The human syndromes Waardenburg syndrome (WS)
type 2a (WS2a) and Tietz syndrome are dominantly
inherited deafness-pigmentation syndromes caused by
mutations in MITF (Amiel et al., 1998; Hughes et al.,
1994; Smith et al., 2000; Tassabehji et al., 1994).
Waardenburg syndrome was first described as a syn-
drome combining pigmentary defects of the iris and of
the hair of the head with congenital deafness and various
facial abnormalities (Waardenburg, 1951). Patients with
the WS2a subtype of WS2 have identified mutations in
the gene MITF, comprising approximately 15% of all
patients with the WS2 phenotype (Read and Newton,
Significance
Melanocytes in the skin and hair follicle reveal their molecular and cellular secrets through the pigmentary
phenotypes readily appreciated by even the casual observer. The characteristics of pigment cells in other
organs, such as the inner ear, are not as immediately accessible. Studying human deafness-pigmentation
syndromes, and their murine counterparts, provides an opportunity to compare and contrast cutaneous and
otic melanocyte populations to understand their functions better. Here, we correlate the auditory capability
and cochlear melanocyte presence of the heterozygousMicrophthalmia-Whitemouse, revealing a selective
survival deficit of these melanocytes that provides insight into human Waardenburg and Tietz syndromes.
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1997). Tietz syndrome is a related dominant syndrome
featuring deafness and generalized skin hypopigmenta-
tion (Tietz, 1963). The two Tietz syndrome pedigrees
reported to date contain distinct mutations in the basic,
DNA-binding region of the MITF gene (Amiel et al., 1998;
Smith et al., 2000). Hence, MITF activity appears to be
important both for proper pigmentation and for hearing
function in humans. The presence of neural crest-derived
melanocytes in the inner ear (Hilding and Ginzberg, 1977;
Steel and Barkway, 1989; Steel et al., 1987) substantiates
their role in hearing.
Mouse coat color mutants have been invaluable both
for defining the genetic requirements of melanocyte
development and for demonstrating the importance of
melanocytes in the development of the auditory system.
Experimental evidence supporting the importance of
melanocytes for hearing function was obtained from an
analysis of the murine coat color mutant viable dom-
inant spotting (KitW–v). The absence of melanocytes
from the stria vascularis in KitW–v/W–v mice, together
with the loss of endocochlear potential (EPs) from the
substantial majority of these mice, both strengthened
the basis for the claim that strial melanocytes are
derived from the neural crest and established the
requirement for melanocytes in the maintenance of
normal structure and function of the stria vascularis
(Steel and Barkway, 1989). The signaling pathway
linking activation of KIT with the enhanced phos-
phorylation, ubiquitination, and degradation of MITF
(Hemesath et al., 1998; Wu et al., 2000) may account
for similarities between the pigmentary and hearing
phenotypes observed in individuals with deafness-
pigmentation syndromes attributed to mutations in KIT
or MITF.
However, one perplexing problem in the field of human
deafness-pigmentation syndromes is the disparity
between the cutaneous pigmentation phenotype, which
can be minimal, and the prevalence of deafness, which is
often high. The extent of white spotting in WS2 is often
minimal, limited to a white forelock, the iris, and/or small
areas of the skin. In contrast, the reported incidence of
congenital deafness in WS2 patients is 77% (Liu et al.,
1995). Likewise, patients with Tietz syndrome have a
limited cutaneous hypopigmentation phenotype. How-
ever, they are uniformly deaf (Amiel et al., 1998; Smith
et al., 2000; Tietz, 1963). One possibility accounting for
these disparities is that the mutation in MITF affects the
intrinsic survival capabilities of cutaneous melanocytes
differently from that of otic melanocytes, even though
both sets of melanocytes are of neural crest origin.
Another possibility is that cutaneous and otic melano-
cytes remain equivalent in terms of their intrinsic prop-
erties and sensitivity to MITF dosage or dysfunction, but
that the follicular environment in the skin and the
substantially different environment of the cochlear lateral
wall support the survival of MITF-deficient melanocytes in
quite different ways.
In this report, we address the difference between the
mild pigmentation phenotype and often severe hearing
phenotype in WS2 and Tietz by analyzing melanocyte
development and survival in theMitf Mi-wh/+mouse. Most
mice with mutations in Mitf do not have a visible
heterozygous phenotype, with homozygosity for a mutant
Mitf allele required for a pigmentary aberration in the coat.
However, a small set of Mitf mutants with heterozygous
phenotypes, Mitf Mi–or/+ and Mitf Mi-wh/+, have mild pig-
mentary phenotypes, rendering such mutants appropriate
both phenotypically and genetically as models for these
human conditions. Here, we show that the cochlear
structural abnormality previously described in Mitf Mi-wh/+
mice (Deol, 1967, 1970) is accompanied by a functional
hearing deficit, similar to that described previously with
KitW–v/W–v mice (Steel and Barkway, 1989). Although a
limited number of melanoblasts migrate to and are
incorporated into the Mitf Mi-wh/+ stria vascularis during
development, they fail to survive in the cochlear environ-
ment during early postnatal life. These findings provide
additional information to implicate MITF as an important
melanocyte survival factor (McGill et al., 2002) in the
cochlear environment and may account for the difference
in severity between the cutaneous and cochlear pigmen-
tary phenotypes in certain congenital disorders of pig-
mentation.
Results
Auditory brainstem responses, otoacoustic
emissions and endocochlear potentials ofMitf Mi-wh/+
mice
C57BL6-MitfMi-wh/+ mice, in addition to possessing
altered cochlear structure, have a grayish-brown coat
color and ventral white spot that distinguish them from
wild-type littermates and C57BL6-MitfMi-wh/Mi-wh homo-
zygotes at an early age (Figure S1). The work of Deol
(Deol, 1967, 1970) established that cochlear structural
abnormality was a feature of certain homozygous Mitf
mutants as well as C57BL6-MitfMi-wh/+mice. Specifically,
the stria vascularis was described to be ‘abnormal in its
entirety’ (Deol, 1970), with ‘severe dedifferentiation and
cellular migrations’ noted in the cochlear duct and saccule
in most ears (Deol, 1970). However, a formal assessment
of hearing function was not performed. To determine the
hearing function of MitfMi-wh/+ mice, we first measured
the auditory brainstem responses (ABRs) as a function of
age. ABRs were measured on C57BL6-MitfMi-wh/+ mice
and their wild-type littermates at P18, P28, and P45. At
P18, only one of two MitfMi-wh/+ mice tested exhibited a
detectable ABR, which was limited to the 4- and 12-kHz
frequencies, with no measurable ABRs detected at
frequencies <4 kHz or 24 kHz. Five of five MitfMi-wh/+
mice tested at P28 demonstrated a measurable ABR at
frequencies ranging from 4 kHz through 24 kHz, but the
threshold for response was higher for MitfMi-wh/+ mice
throughout the frequency range tested. For example, the
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mean threshold shift for P28 Mitf Mi-wh/+ mice at 12 kHz
was 70 dB. At P45, no measurable ABRs were detected
in two of two Mitf Mi-wh/+ mice at ranges from 1 kHz
through 24 kHz (Table 1, Figure 1A). Representative
waveforms are shown in Figure 1B. At P28, the mean
ABRs for the wild-type and Mitf Mi-wh/+ mice differed
significantly (Figure 1A and legend to Figure 1). Despite
the significant threshold shift between wild-type and
Mitf Mi-wh/+ ABRs, the Mitf Mi-wh/+ mice exhibited a
Preyer reflex. Together, these results suggest that
Mitf Mi-wh/+ mice in the P18–45 age range have a
profound sensorineural hearing deficit.
To provide information on outer hair cell (OHCs)
function in Mitf Mi-wh/+ mice, distortion product otoacou-
stic emissions (DPOAE) were obtained on two Mitf Mi-wh/
+ P28 mice and compared to wild-type littermates.
DPOAE are shown in Figure 2. In wild-type mice, the
amplitude of the DPOAE (8.7 kHz, F2/F1 = 1.2,
L1 = L2  10 dB) exceeded the noise floor from 50 to
80 dB sound pressure level (SPL) at 12 kHz. In the
Mitf Mi-wh/+ mice, the DPOAE amplitude did not
exceed the noise floor. Similar results were obtained at
16 kHz.
Endocochlear potentials are absent in KitW-v/W-v mice
(Steel and Barkway, 1989), which lack both coat pigmen-
tation and strial intermediate cells. The ABR and DPOAE
abnormalities we found in Mitf Mi-wh/+ mice prompted us
to evaluate the EP in these mice as well. Endocochlear
potential measurements were obtained from two wild-
type and three Mitf Mi-wh/+ mice representing two litters
at ages P34 and P36. While EP values were >100 mV in
the two wild-type mice examined, repeated measure-
ments on the three Mitf Mi-wh/+ mice revealed the
absence of an EP (Table 2, Figure S2).
Stria vascularis structure, cochlear hair cell integrity
and strial melanocyte distribution inMitf Mi-wh/+mice
To determine the structure of the stria vascularis of
Mitf Mi-wh/+ mice at ages before and after the P34 and
P36 time points where EP was absent, histologic
sections were examined from cochleas of Mitf Mi-wh/+
mice and their wild-type littermates at P28 and P37. The
striae vascularis of wild-type mice at these stages
(Figures 3A and S3A,E,F) show condensed marginal cell
nuclei present in a thin cell layer adjacent to the scala
media, exhibiting extensive interdigitations that obscure
the boundaries between cell layers. In contrast, the striae
vascularis of Mitf Mi-wh/+ mice exhibit enlarged marginal
cell nuclei with prominent nuclear markings. Most prom-
inently, the Mitf Mi-wh/+ stria vascularis shows a sharp
boundary between the marginal cell layer and basal cell
layer that differs from the extensively interdigitated
boundary present in the wild-type stria vascularis (Fig-
ures 3B and S3B,F,H).
Whole-mount phalloidin staining of the P28 Mitf Mi-wh/+
organ of Corti was performed to determine whether loss
of cochlear hair cells correlated with degeneration of the
stria vascularis and loss of auditory function. Inner hair
cells were normal at P28 in all (n = 5) Mitf Mi-wh/+ mice
examined. In contrast, there was extensive loss of OHCs
at P28. Outer hair cells loss increased progressively from
apex (Figure 3C) to base (Figure 3D). Quantitative cytoc-
Table 1. Auditory brainstem response (ABR) thresholds of P18, P28, and P45 C57BL6-MitfMi-wh/+ (Mu) mice and C57BL6-+/+ (Wt) littermates at
various frequencies (kHz)
ID Genotype Sex
ABR thresholds
1 kHz 2 kHz 4 kHz 8 kHz 12 kHz 16 kHz 24 kHz
H1-p28 Wt F a a 35 a 20 a 33
H3-p28 Wt F a a 32 29 15 35 40
H5-p28 Wt F a a 41 a 30 a 35
H7-p28 Wt F a a 33 33 19 34 38
H2-p28 Mu M a a 100 92 96 95 NR
H4-p28 Mu F a a 95 92 85 90 104
H6-p28 Mu M a a 90 a 87 a 104
H8-p28 Mu F a a 98 a 94 a 104
H9-p18 Wt F NR NR 66 a 36 a 45
H10-p18 Mu M NR NR NR a NR a a
H11-p18 Wt M 96 84 49 a 20 a 50
H12-p18 Mu F NR NR 95 a 90 a NR
H13-p18 Wt M 94 80 40 a 26 a 47
H10-p45 Mu M NR NR NR a NR a NR
H11-p45 Wt M 95 75 45 a 25 a 45
H12-p45 Mu F NR NR NR a NR a NR
H13-p45 Wt M NR 95 60 a 25 a 45
NR = No response observed at 105 dB SPL.
aNot recorded.
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ochlear analysis revealed that OHC loss was 10.0 (±4.1)%
at approximately midway between the apex and base,
increasing to 37.5 (±33.9)% midway between the mid-
point and the base, and reaching 76.1 (±16.5)% loss at
the cochlear base (Table 3, Figure S4). The difference
between the mean percent OHC loss at the midpoint and
the base was highly significant (P < 0.001, two-tailed
t-test with unequal variances). Because of the role of
OHCs as cochlear amplifiers (Ashmore, 2008; Fettiplace
and Hackney, 2006; Kachar et al., 1986; Raphael and
Altschuler, 2003), the selective loss of these OHCs, at
least at P28, is the likely explanation of the marked
difference in ABR threshold observed between wild-type
and Mitf Mi-wh/+ mice.
The studies previously described demonstrate hearing
loss, greatest at higher frequencies, associated with
degeneration of the stria vascularis and loss of the EP as
the likely cause of the loss, and associated with progres-
sive loss of OHCs approaching the cochlear base. To
determine whether melanocyte loss or dysfunction
determines the cochlear phenotype in Mitf Mi-wh/+ mice,
we analyzed cochlear melanocyte development and
survival in Mitf Mi-wh/+ embryos and postnatal mice.
Embryonic analysis of another dominant-negative Mitf
heterozygote, Mitf mi/+, has revealed that fewer melano-
A B
Figure 2. Distortion product otoacoustic
emissions (DPOAE) for postnatal 29 (P29)
wild-type and MitfMi-wh/+ littermates at
12 kHz (A) and 16 kHz (B). At 12 kHz
(geometric mean of the primaries), the 2F1
–F2 levels recorded from wild-type mouse
are about 20–30 dB higher than from
MitfMi-wh/+ littermate. At 16 kHz, they are
similarly higher.
Table 2. Endocochlear potentials (EP) of wild-type and MitfMi-wh/+
littermates
Mouse age Genotype EP (mV)
P34 C57BL6-+/+ 110
P36 C57BL6-+/+ 130
P34 C57BL6-MitfMi-wh/+ 0
P34 C57BL6-MitfMi-wh/+ 0
P36 C57BL6-MitfMi-wh/+ 0
A B
Figure 1. Auditory brainstem responses (ABR) of +/+ andMitfMi-wh/+ mice. (A) Postnatal day 18 (P18)MitfMi–wh/+ mice (○) exhibited a 63dB ABR
threshold shift compared to wild-type (+/+) littermates (●) at 12-kHz frequency. Similarly, P28 MitfMi–wh/+ mice exhibited a 70 dB ABR threshold
shift compared to wild-type littermates at 12-kHz frequency. P45 MitfMi–wh/+ mice had an absence of ABR waveforms, with an ABR threshold
shift of >80 dB. Error bars signify standard deviation from the mean. A value of 105 dB SPL was used by convention for graphing and calculation
purposes when no response was detected. P < 0.05 for P28 comparisons ofMitfMi-wh/+ and wild-type responses at 8 and 16 kHz. For comparison
of responses at 4, 12, and 24 kHz, P < 1 9 106, 1 9 105, and 1 9 104, respectively, by two-tailed Student’s t-test. (B) Comparison of ABR
waveforms of +/+ (H1, P28) and MitfMi–wh/+ (H4, P28) littermates at 12 kHz. ABR waveforms are no longer evident at 20 dB in the wild-type
mouse, but disappear at 85 dB in the MitfMi–wh/+ littermate.
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blasts are present in the heterozygote relative to wild-
type embryos at similar developmental stages (Hornyak
et al., 2001). Mitf Mi-wh/+ mice were intercrossed with
Dct-lacZ transgenic mice (Hornyak et al., 2001) to gener-
ate embryos for analysis. At E12.5, wild-type embryos
contained numerous lacZ–expressing melanoblasts in the
otic vesicle (OV) region (Figure 4A). In contrast, Mitf Mi-
wh/+ embryonic littermates contained significantly fewer
lacZ-positive melanoblasts in the OV region (Figure 4B).
Like Mitf mi/+ mice, Mitf Mi-wh/+ mice have fewer mela-
noblasts in the cephalic region at E10.5 and E12.5
(Figure 4C).
To investigate the presence and distribution of mela-
nocytes in the postnatal cochlea, Dct-lacZ transgenic
mice were also used. In wild-type cochleas, lacZ-express-
ing melanocytes describe an approximate one and three-
quarters turn spiral from the cochlear base through the
apex (Figures 5 and S5). Compared to the wild-type
cochlea, the P1 Mitf Mi-wh/+ cochlea contains fewer lacZ-
positive melanocytes than the wild-type cochlea. These
melanocytes appear to be localized at the central stria
(Figure S6). P7 Mitf Mi-wh/+ cochleas contain either very
few (Figure 6A) or no (Figures 5 and S5) lacZ-positive
melanocytes. P14 and P28 Mitf Mi-wh/+ cochleas contain
no lacZ-positive melanocytes (Figures 5, S5 and S6).
A B
C D
E F
Figure 3. Morphology of +/+ andMitf Mi-wh/+ stria vascularis and cochlear hair cells. Examples from P28Mitf Mi-wh/+ mouse (B) and +/+ littermate
(A) are shown. (A) Stria vascularis of P28 wild-type mouse. Arrowheads point to the condensed marginal cell (mc) nuclei and basal cell (bc) nuclei
of the stria vascularis, with grouped arrowheads defining the boundary between the stria vascularis (sv) and the spiral ligament (sl). The
boundaries between cell layers in the stria vascularis are obscured by faint interdigitations. (B) Stria vascularis of P28 MitfMi–wh/+ mouse. In this
panel, the grouped arrowheads delineate the sharp boundary present between the marginal and basal cell layers. The marginal cell (mc) nuclei are
rounded rather than condensed. (C) Apex of P28 MitfMi–wh/+ cochlea. Whole-mount phalloidin staining reveals no inner hair cell (IHC) loss, with
sporadic loss of outer hair cells (OHCs). (D) Whole-mount phalloidin staining of base of P28 MitfMi-wh/+ cochlea shows similar OHC loss with
preservation of IHC layer. (E) Apex of P28 wild-type (+/+) littermate cochlea. No IHC or OHC loss is observed. (F) Base of P28 wild-type (+/+)
littermate cochlea. No IHC or OHC loss is observed. Scale bar (C–F), 20 lm. Other symbols: sm, scala media.
Table 3. Outer hair cell loss in MitfMi-wh/+ cochleas as a function of
distance from apex
Mouse
At 50% At 75% At 100%
%
OHCsa
%
dist
%
OHCsb
%
dist
%
OHCsc
%
dist
Mitf2 10.9 48.4 66.8 79.8 86.1 100
Mitf7 9.9 51 8.6 70.1 73.7 100
Mitf8 11.2 48.5 6.1 72.7 48.8 100
Mitf11 3.5 46.8 26.2 74.3 81.9 100
Mitf14 14.7 50 79.8 76.9 90.2 100
Average 10.0 48.9 37.5 74.8 76.1 100.0
Stdev 4.1 1.6 33.9 3.7 16.5 0.0
aThe percentage of OHCs absent at the closest point to the 50%
point between the apex and base was determined.
bThe percentage of OHCs absent at the closest point to the 75%
point between the apex and base was determined.
cThe percentage of OHCs absent at the base was determined.
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The striking loss of melanocytes in the early postnatal
cochleas of Mitf Mi-wh/+ mice prompted us to investigate
whether the loss of melanocytes was progressive or
abrupt. To determine this, Dct-lacZ-expressing cochleas
were obtained at intermediate time points between P1
and P7 (Figure 6A). Dct-lacZmelanocytes were quantified
in the first apical half-turn (Figure 6B) to characterize
melanocyte loss. The results of this analysis (Figure 6C)
suggest that Mitf Mi-wh/+ cochlear melanocyte loss is
progressive rather than abrupt, with a decrease in
melanocyte number over the P5-P7 stages leading to a
total absence by P10.
Discussion
Here, we show that hearing dysfunction in Mitf Mi-wh/+
mice is associated with an absence of melanocytes from
the postnatal cochlea. The complete absence of cochlear
melanocytes inMitf Mi-wh/+ mice following the immediate
postnatal period results from a deficiency in melanocyte
survival, although a relative deficiency in melanocyte
migration to the cochlea during embryogenesis may
contribute to their loss. Because current techniques limit
the measurement of hearing function in neonatal mice,
we cannot say for certain whether the reduced number of
melanocytes in the neonatal cochlea alone affects hearing
function. We also show that these mice have selective
OHC loss, providing an explanation for the elevated ABR
threshold, with the maintenance of a Preyer reflex,
observed at P18, P28, and P45. Similar to KitW–v/W-v mice
(Steel and Barkway, 1989; Steel et al., 1987) and KitW–s/
W-s rats (Araki et al., 2002), Mitf Mi-wh/+ mice lack strial
melanocytes, a positive EP, and feature structural abnor-
malities of the stria vascularis including distorted marginal
and basal cell structure and loss of interdigitations. In
contrast to these mice, the Mitf Mi-wh/+ mutant is largely
pigmented at the ages we made our findings and retains
its pigment throughout adult life. The disparity between
the cochlear and cutaneous pigmentary phenotypes
suggests either that intrinsic differences between otic
and cutaneous melanocytes account for their differential
survival or that the cochlear and follicular environments
differ in supporting the survival of melanocytes partially
deficient in Mitf.
A B C
Figure 4. Embryonic melanoblasts in cephalic and otic vesicle (OV) regions of Dct–lacZ transgenic +/+ and MitfMi-wh/+ embryos. (A) At E12.5,
numerous Dct-lacZ+melanoblasts are present in the periorbital region, throughout the cephalic region, and in the region of the OV in this wild-type
transgenic embryo. (B) Fewer melanoblasts in the cephalic and OV region of E12.5MitfMi–wh/+ transgenic embryonic littermate. (C) Quantification
of Dct–lacZ melanoblast numbers in cephalic region of MitfMi-wh/+ and +/+ embryonic littermates at E10.5 and E12.5. Melanoblasts were counted
as described in Methods. P < 0.10 by Student’s two-tailed t-test for difference between MitfMi-wh/+ and +/+ embryos at E12.5.
Figure 5. Stria vascularis melanocytes in neonatal +/+ and MitfMi-wh/+ mice. +/+ and MitfMi–wh/Mi-wh mice were intercrossed with Dct-lacZ
transgenic mice to permit visualization of cochlear melanocytes after staining for b-galactosidase activity. Wild-type cochlear melanocytes are
present in a continuous, 1 3/4 turn configuration in whole-mount P1, P7, P14, and P28 cochleas (top row). MitfMi-wh/+ cochlear melanocytes
(bottom row) are more sparse and distributed intermittently along the stria vascularis at P1, yet still present in a similar distribution as in the wild-
type cochlea. In most P7 cochleas and in older (P14 and P28) cochleas, MitfMi-wh/+ melanocytes (left) are no longer visible.
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The generalized lightening of the coat color and
ventral white belly spot of the Mitf Mi-wh/+ mouse
results from a heterozygous, Ile212Asn mutation in the
basic, DNA-binding region of Mitf (Steingrı´msson et al.,
1994). As coat color dilution in mice, because of the
follicular localization of their melanocytes, is analogous
to hypopigmentation in humans, the pigmentary charac-
teristics of the Mitf Mi-wh/+ mouse combine both the
hypopigmentation described in Tietz syndrome patients
as well as the localized spotting of WS. Our demon-
stration of the hearing abnormality present in these mice
reinforces the notion of their similarity to these human
syndromes, because Tietz syndrome patients are invari-
ably deaf (Amiel et al., 1998; Smith et al., 2000) and
approximately 75% of WS patients are deaf (Read and
Newton, 1997). The two Tietz syndrome mutations in
the MITF gene are also located in the basic region of the
gene, whose basic region sequence is 100% conserved
between mice and humans (Tachibana et al., 1994). One
is an Asn210Lys substitution (Smith et al., 2000) and the
other a delArg217 mutation, identical to the mutation
responsible for another Mitf mutant allele, Mitf mi.
However, the Mitf mi/+ mouse does not have coat color
dilution and has a relatively mild phenotype with small
ventral white belly spots and no apparent cochlear
abnormality (Deol, 1970). This difference in phenotype
associated with an identical mutation in humans and
mice indicates either that the activity of MITF/Mitf is not
exactly the same in each species or that the absolute
requirement of Mitf for proper melanocyte development
and differentiation differs subtly between species.
Patients with the WS2 phenotype and mutations in
the basic region have also been described (Chen et al.,
2010; Pingault et al., 2010).
The unique phenotypic characteristics of the Mitf Mi-wh/
+ mouse may not be due exclusively to the specific
mutation, but to interactions between mutant and wild-
type splice isoforms of the Mitf-M protein, the transcribed
form specific to the neural crest-derived melanocyte
(Amae et al., 1998). Mitf-M, which dimerizes in vitro
(Hemesath et al., 1994), is expressed in two distinct
isoforms, (+) Mitf-M and () Mitf-M, distinguished by the
presence or absence of a 6-amino acid stretch immedi-
ately N-terminal to the DNA-binding basic region domain
(Hodgkinson et al., 1993; Steingrı´msson et al., 1994). In
the context of the Mi-wh mutation, the (+) isoform was
found to exhibit an enhanced ability to stabilize DNA
binding in a heterodimeric complex with the transcription
factor TFE3 (Hemesath et al., 1994), an effect that was
specific for this mutant form of the protein and not for the
mi mutant. Mitf possesses an anti-proliferative effect,
mediated by the (+) Mitf isoform (Bismuth et al., 2005),
due to its induction of the p21CIP1 cyclin-dependent kinase
inhibitor (Carreira et al., 2005) and p16INK4A (Loercher
et al., 2005). As a diminished number of melanoblasts are
also found inMitf mi/+ embryos (Hornyak et al., 2001), it is
unlikely that preferential activity or stabilization of (+)
isoform-containing heterodimers in Mitf Mi-wh/+ melano-
cytes contributes to the diminished number of melano-
blasts noted during embryonic development. Perhaps,
isoform-specific regulatory activites or neomorphic
activities potentially attributable to the MitfMi-wh protein
(Steingrı´msson, 2010) contribute to the apparent, com-
promised environment-dependent survival that appears to
be quite specific for heterozygotes. It is also possible that
there is exacerbated loss of both cochlear and follicular
melanocytes during the neonatal time period, with differ-
ential loss in the cochlea resulting in complete melanocyte
A
B C
Figure 6. Selective melanocyte loss from
early postnatal MitfMi-wh/+ cochleas. (A)
Representative X-gal-stained Dct-lacZ
cochleas from P1 to P7+/+ and MitfMi-wh/+
mice show selective loss of cochlear
melanocytes through postnatal day 7. (B)
Representation of apical first half-turn used
for counting MitfMi-wh/+ cochlear
melanocytes. (C) Quantification of cochlear
MitfMi-wh/+ melanocytes. Individual
melanocytes in the area depicted by cross-
hatching in (B) were counted. Progressive
loss of cochlear melanocytes is observed
from P5 to P10. * indicates P < 0.005 for
comparison. Error bars represent standard
deviation from the mean.
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absence with resulting hearing dysfunction, but sufficient
retention in the hair follicle to establish a melanocyte stem
cell population for recurrent hair pigmentation throughout
successive hair cycles.
In summary, we have demonstrated that the profound
hearing deficit exhibited by Mitf Mi-wh/+ mice is due to the
absence of melanocytes in the mature stria vascularis.
Although any loss of cochlear melanocytes from humans
with Waardenburg and Tietz syndromes may be highly
variable and occur on a distinct time course, our findings
nonetheless suggest strategies, including the delivery of
growth factors to the cochlear environment or the
introduction of melanocyte stem cells (Nishimura et al.,
2002), that could be devised to maintain the presence of
melanocytes in patients with these disorders to preserve
cochlear structure and some degree of auditory function.
Methods
Characterization, breeding, and analysis of
embryonic and adult mice
C57BL/6-Mitf Mi-wh/Mi-wh homozygotes were obtained from the
colony of Dr. Lynn Lamoureux, Texas A&M College of Veterinary
Medicine, and used to establish a colony for these experiments
maintained on the C57BL/6 background by serial backcross. C57BL/
6- Mitf Mi-wh/+ progeny or their C57BL/6-+/+ littermates were used
for determination of the ABR, EP, DPOAE, and for histological and
immunohistochemical studies. Tg(Dct-lacZ) transgenic mice (Hornyak
et al., 2001) maintained on the CD1 background were intercrossed
with C57BL6– Mitf Mi-wh/+ or C57BL6-Mitf Mi-wh/Mi-wh mice to obtain
Tg(Dct-lacZ); Mitf Mi-wh/+ embryos or neonates for analysis of
melanocyte presence in the cochlea and numbers in the cephalic
region. Cephalic melanoblasts were counted as previously described
(Hornyak et al., 2001). Animal care, handling, and procedures were
approved by the Institutional Animal Care and Use Committees of the
Henry Ford Health System, The University of Michigan, and the
National Cancer Institute.
Noon of the day a vaginal plug was found was defined as E0.5, and
embryos were harvested at various time points thereafter. Embryos
and mice were genotyped either by inference from parental geno-
types, by observation of neonatal skin or coat color, or, in select
cases, by using PCR to amplify Mitf exon 7 from DNA purified from
yolk sacs or tails. The primers utilized were
Forward: 5′-GGC CGT TGT AGA ATG AAG TG-3′
Reverse: 5′-CCT GCC TCA AGC CCC AAG CTC-3′.
Amplicons were sequenced for Mitf Mi-wh mutation detection
using sequencing primer MITFSEQF 5′- TCA TAA ATG AGG AGA CTC
CAA AGG -3′. For detecting the presence of the Dct-lacZ transgene,
PCR was used with primer pairs for detecting lacZ and RAPSYN as
previously described (Hanley and Merlie, 1991).
Whole-mount staining and melanocyte quantification
of embryos and cochleas
Embryos were microdissected and fixed in 0.4% paraformaldehyde
(PFA) for periods of 2–4 h, depending on their developmental stages,
and washed in phosphate-buffered saline (PBS), pH 7.4. Embryos
were stained in X-Gal buffer (2 mM MgCl2, 0.02% NP-40, 2 mM
K3Fe(CN)6, 2 mM K4Fe(CN)6 containing 0.05% X-Gal dissolved in
dimethylformamide). After the reaction, the samples were washed
and postfixed in 4% PFA. For Mitf Mi-wh/+ embryos, and cephalic
melanoblasts were counted as previously described (Hornyak et al.,
2001). To quantify postnatal cochlear melanocytes, cells from X-gal-
stained photomicrographs were counted in the first apical half-turn as
depicted in Figure 6B.
Auditory brainstem response measurement
Animals were anesthetized (mice: ketamine 65 mg/kg, xylazine
3.5 mg/kg, and acepromazine 2 mg/kg). Body temperature was
maintained through the use of water circulating heating pads and heat
lamps. Additional anesthetic (ketamine and xylazine)was administered
if needed to maintain anesthesia depth sufficient to insure immobili-
zation and relaxation. Auditory brainstem responses were recorded in
an electrically and acoustically shielded chamber (Acoustic Systems,
Austin, TX, USA). Needle electrodes (Grass E2 platinum) were placed
at vertex (active) and the test ear (reference) and contralateral ear
(ground) pinnae. Tucker Davis Technologies (TDT) System II hardware
and SIGGEN/BIOSIG software (TDT, Alachua, FL, USA) were used to
present the stimulus and record responses. Tones were delivered
through a Beyer driver (Beyer Dynamic Inc., Farmingdale, NY, USA;
Aluminum-shielded enclosure made in house), with the speculum
placed just inside the tragus. Stimulus presentation was 15 ms tone
bursts, with 1 ms rise/fall times, presented 10/s. Up to 1024
responses were averaged for each stimulus level. Responses were
collected for stimulus levels in 10 dB steps at higher stimulus levels,
with additional 5 dB steps near threshold. Thresholds were interpo-
lated between the lowest stimulus level, where a response was
observed, and 5 dB lower, where no response was observed.
Distortion product otoacoustic emissions
measurement
Animals were anesthetized as described above. The primary tones,
F1 and F2, were set at a ratio of F2/F1 = 1.2. The intensity of F1 (L1)
was varied in 5 or 10 dB steps, with the intensity of F2 (L2) held at
10 dB quieter than L1. The DPOAE was measured at 2F1–F2. Tones
were presented via two Beyer drivers (Aluminum-shielded enclosure
made in house; Beyer Dynamic Inc) connected through an Etymotic
microphone (ER 10B+; Etymotic Research, Inc., Elk Grove Village, IL,
USA). Tucker Davis Technologies System II hardware and SIGGEN/
BIOSIG software were used to present the stimuli and record
responses.
Recording of the endocochlear potential
Animals were anesthetized as described above and given a dose of
glycopyrrolate (0.2 mg/kg). They were placed into a headholder. The
external pinna was removed and soft tissue dissected away from the
bulla. The ossicles and tympanic membrane were removed, and
some of the bulla wall was removed to allow clear visualization of the
cochlea. A small opening was made in the otic capsule over the stria
vascularis for penetration of a glass micropipette (filled with 1.5 M
KCl) into scala media. The micropipette was inserted with a hydraulic
microdrive. The electrode signals were amplified by a capacity-
compensated dc preamplifier and recorded using TDT hardware and
‘chart recorder’ software written in-house. Animals were euthanized
at the end of the recording.
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Supporting Information
Additional Supporting Information may be found in the
online version of this article:
Figure S1. Coat color phenotypes of MitfMi–wh mutant
mice.
Figure S2. Representative EP measurement of +/+ and
MitfMi-wh/+ mice.
Figure S3. Cochlear and hair cell morphology in +/+ and
MitfMi-wh/+ mice.
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Figure S4. Representative cytocochleograms of a
MitfMi-wh/+ mouse at P28.
Figure S5. Additional examples of X-gal-stained, Dct-
lacZ wild-type and MitfMi-wh/+ cochleas at P1, P7, P14,
and P28, depicting progressive and persistent loss of
cochlear melanocytes in MitfMi-wh/+ post-natal mice.
Figure S6. Cryosections of X-gal-stained, Dct-lacZ wild-
type and MitfMi-wh/+ cochleas at P1, P7, P14, and P28,
demonstrating the localization of Dct-lacZ-expressing
melanocytes in the stria vascularis and their progressive
loss from MitfMi-wh/+ striae.
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